Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Astex Pharmaceuticals, Inc.
Charite University, Berlin, Germany
Teva Branded Pharmaceutical Products R&D, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
Baylor College of Medicine
M.D. Anderson Cancer Center
Poitiers University Hospital